Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503097 · ClinicalTrials.gov registry record
Genetic Testing for Men With Metastatic Prostate Cancer
A clinical trial, sponsored by University of Washington.
- Terminated
- Registry status
- 799
- Enrollment target
NCT03503097 is a clinical trial that was terminated before completion, run by University of Washington. The registered enrollment target is 799 participants.
The verdict
NCT03503097 was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- 799 participants
- Enrollment target
Study Summary
This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
- OTHER Genetic Testing
- BEHAVIORAL Questionnaire
- OTHER Genetic Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 799 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2025-09-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03503097
The ClinicalTrials.gov registry entry for NCT03503097 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 799 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT03503097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03503097 about?
NCT03503097 is a clinical study titled "Genetic Testing for Men With Metastatic Prostate Cancer". This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns ab...
What is the current status of trial NCT03503097?
This trial is currently terminated. The enrollment target is 799 participants. The study started on 2017-08-21. Estimated completion is 2025-09-17.
What interventions are being tested in trial NCT03503097?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Genetic Testing (OTHER), Questionnaire (BEHAVIORAL), Genetic Counseling (OTHER).
Who is sponsoring clinical trial NCT03503097?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.